TrialInternational journal of molecular sciences2017

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.

David Capper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.